Postsurgical cystoid macular edema

European Journal of Ophthalmology

Volumn 21, Issue SUPPL.6, 2011, Pages 62-68

  Zur, Dina ^a   Fischer, Naomi ^a   Tufail, Adnan ^b   Monés, Jordi ^c   Loewenstein, Anat ^a  

^a TEL AVIV SOURASKY MEDICAL CENTER   (Israel)

^b MOORFIELDS EYE HOSPITAL   (United Kingdom)

^c CENTRO MÉDICO TEKNON   (Spain)

Author keywords

Cystoid macular edema; Macular edema; Postoperative; Treatment

Indexed keywords

ACETAZOLAMIDE; ANGIOGENESIS INHIBITOR; BEVACIZUMAB; CARBONATE DEHYDRATASE INHIBITOR; CORTICOSTEROID; DICLOFENAC; INDOMETACIN; KETOROLAC TROMETAMOL; NONSTEROID ANTIINFLAMMATORY AGENT; PREDNISOLONE; PROSTAGLANDIN SYNTHASE INHIBITOR; TRIAMCINOLONE ACETONIDE;

ARTICLE; CATARACT EXTRACTION; COMORBIDITY; DIABETIC MACULAR EDEMA; DIFFERENTIAL DIAGNOSIS; EYE DISEASE; HUMAN; INCIDENCE; INFLAMMATION; INTRAOCULAR PRESSURE; INTRAOPERATIVE PERIOD; LENS IMPLANT; LOW LEVEL LASER THERAPY; OPTIC DISK; OPTICAL COHERENCE TOMOGRAPHY; PEROPERATIVE COMPLICATION; POSTOPERATIVE COMPLICATION; PRIORITY JOURNAL; PSEUDOPHAKIA; RETINA FLUORESCEIN ANGIOGRAPHY; RETINA MACULA AGE RELATED DEGENERATION; RETINA MACULA CYSTOID EDEMA; RETINA OUTER NUCLEAR LAYER; SIDE EFFECT; TREATMENT INDICATION; UNSPECIFIED SIDE EFFECT; VISUAL ACUITY; VISUAL IMPAIRMENT; VITREORETINAL SURGERY; VITREOUS BODY;

ADRENAL CORTEX HORMONES; ANTI-INFLAMMATORY AGENTS; CATARACT EXTRACTION; DIAGNOSIS, DIFFERENTIAL; FLUORESCEIN ANGIOGRAPHY; HUMANS; MACULAR EDEMA; RISK FACTORS; TOMOGRAPHY, OPTICAL COHERENCE; VITRECTOMY;

EID: 79959941996     PISSN: 11206721     EISSN: None     Source Type: Journal    
DOI: 10.5301/EJO.2010.6058     Document Type: Article

References (37)

1. Gass JD, Norton EW. Fluorescein studies of patients with macular edema and papilledema following cataract extraction. Trans Am Ophthalmol Soc 1966; 64: 232-49.
2. Irvine AR. Cystoid maculopathy. Surv Ophthalmol 1976; 21: 1-17.
3. Henderson BA, Kim JY, Ament CS. Clinical pseudophakic cystoid macular edema: risk factors for development and duration after treatment. J Cataract Refract Surg 2007; 33: 1550-8.
4. Flach AJ. The incidence, pathogenesis and treatment of cystoid macular edema following cataract surgery. Trans Am Ophthalmol Soc 1998; 96: 557-634.
5. Shimura M, Yasuda K, Nakazawa T, et al. Panretinal photocoagulation induces pro-inflammatory cytokines and macular thickening in high-risk proliferative diabetic retinopathy. Graefes Arch Clin Exp Ophthalmol 2009; 247: 1617-24.
6. Neal RE, Bettelheim FA, Lin C, Winn KC, Garland JS, Zigler JS. Alterations in human vitreous humour following cataract extraction. Exp Eye Res 2005; 80: 337-47.
7. Rossetti L, Autelitano A. Cystoid macular edema following cataract surgery. Curr Opin Ophthalmol 2000; 11: 65-72.
8. Hruby K. The first description of the Irvine syndrome. Klin Monatsbl Augenheilkd 1985; 187: 549-50.
9. Miyake K, Ibaraki N. Prostaglandins and cystoid macular edema. Surv Ophthalmol 2002; 47(Suppl 1): S203-18.
10. Tolentino FI, Schepens CL. Edema of the posterior pole after cataract extraction: a biomicroscopic study. Arch Ophthalmol 1965; 74: 781-6.
11. Iliff WJ. Aphakic cystoid macular edema and the operating microscope: is there a connection? Trans Am Ophthalmol Soc 1985; 83: 476-500.
12. Schmier JK, Halpern MT, Covert DW, Matthews GP. Evaluation of costs for cystoid macular edema among patients after cataract surgery. Retina 2007; 27: 621-8.
13. Cohen SM, Davis A, Cukrowski C. Cystoid macular edema after pars plana vitrectomy for retained lens fragments. J Cataract Refract Surg 2006; 32: 1521-6.
14. Kraff MC, Sanders DR, Jampol LM, Lieberman H. Effect of primary capsulotomy with extracapsular surgery on the incidence of pseudophakic cystoid macular edema. Am J Ophthalmol 1984; 98: 166-70.
15. Warwar RE, Bullock JD, Ballal D. Cystoid macular edema and anterior uveitis associated with latanoprost use: experience and incidence in a retrospective review of 94 patients. Ophthalmology 1998; 105: 263-8.
16. Arcieri ES, Santana A, Rocha FN. Blood-aqueous barrier changes after the use of prostaglandin analogues in patients with pseudophakia and aphakia. Arch Ophthalmol 2005; 123: 186-92.
17. Solomon LD. Efficacy of topical flurbiprofen and indomethacin in preventing pseudophakic cystoid macular edema: Flurbiprofen-CME Study Group I. J Cataract Refract Surg 1995; 21: 73-81.
18. Peterson M, Yoshizumi MO, Hepler R, Mondino B, Kreiger A. Topical indomethacin in the treatment of chronic cystoid macular edema. Graefes Arch Clin Exp Ophthalmol 1992; 230: 401-5.
19. Rho DS. Treatment of acute pseudophakic cystoid macular edema: diclofenac versus ketorolac. J Cataract Refract Surg 2003; 29: 2378-84.
20. Rossetti L, Chaudhwi H, Dickersin K. Medical prophylaxis and treatment of cystoid macular edema after cataract surgery: the results of a meta-analysis. Ophthalmology 1998; 105: 397-405.
21. Thach AB, Dugel PU, Flindall RJ, Sipperley JO, Sneed SR. A comparison of retrobulbar versus sub-Tenon's corticosteroid therapy for cystoid macular edema refractory to topical medications. Ophthalmology 1997; 104: 2003-8.
22. Heier JS, Topping TM, Baumann W, Dirks MS, Chern S. Ketorolac versus prednisolone versus combination therapy in the treatment of acute pseudophakic cystoid macular edema. Ophthalmology 2000; 107: 2034-8.
23. Jonas JB, Kreissing I, Segenring RF. Intravitreal triamcinolone acetonide for pseudophakic cystoid macular edema. Am J Ophthalmol 2003; 136: 384-6.
24. Boscia F, Furino C, Dammacco R, Ferreri P, Sborgia L, Sborgia C. Intravitreal triamcinolone acetonide in refractory pseudophakic cystoid macular edema: functional and anatomic results. Eur J Ophthalmol 2005; 15: 89-95.
25. Conway MD, Canakis C., Livir-Rallatos C, Peyman GA. Intravitreal triamcinolone acetonide for refractory chronic pseudophakic cystoid macular edema. J Cataract Refract Surg 2003; 29: 27-33.
26. Farber MD, Lam S, Tessler HH, Jennings TJ, Cross A, Rusin MM. Reduction of macular oedema by acetazolamide in patients with chronic iridocyclitis: a randomised prospective crossover study. Br J Ophthalmol 1994; 78: 4-7.
27. Grover S, Apushkin MA, Fishman GA. Topical dorzolamide for the treatment of cystoid macular edema in patients with retinitis pigmentosa. Am J Ophthalmol 2006; 141: 850-8.
28. Catier A, Tadayoni R, Massin P, Gaudric A. Advantages of acetazolamide associated with anti-inflammatory medications in postoperative treatment of macular edema. J Fr Ophtalmol 2005; 28: 1027-31.
29. Weene LE. Cystoid macular edema after scleral buckling responsive to acetazolamide. Ann Ophthalmol 1992; 24: 423-4.
30. Spitzer MS, Ziemssen F, Yoeruek E, Petermeier K, Aisenbrey S, Szurman P. Efficacy of intravitreal bevacizumab in treating postoperative pseudophakic cystoid macular edema. J Cataract Refract Surg 2008; 34: 70-5.
31. Arevalo JF, Maia M, Garcia-Amaris RA, et al, Pan-American Collaborative Retina Study Group. Ophthalmology: intravitreal bevacizumab for refractory pseudophakic cystoid macular edema: the Pan-American Collaborative Retina Study Group results. Ophthalmology 2009; 116: 1481-7.
32. Steinert RF, Wasson PJ. Neodymium: YAG laser anterior vitreolysis for Irvine-Gass cystoid macular edema. J Cataract Refract Surg 1989; 15: 304-7.
33. Lardenoye CWTA, van Schooneveld MJ, Frits Treffers W, Rothova A. Grid laser photocoagulation for macular oedema in uveitis or the Irvine-Gass syndrome. Br J Ophthalmol 1998; 82: 1013-6.
34. Fung WE. Vitrectomy for chronic aphakic cystoid macular edema: results of a national, collaborative, prospective, randomized investigation. Ophthalmology 1985; 92: 1102-11.
35. Harbour JW, Smiddy WE, Rubsamen PE, Murray TG, Davis JL, Flynn HW Jr. Pars plana vitrectomy for chronic pseudophakic cystoid macular edema. Am J Ophthalmol 1995; 120: 302.
36. Shepard DD. The fate of eyes from which intraocular lenses have been removed. Ophthalmic Surg 1979; 10: 58-60.
37. Price FW Jr, Whitson WE. Natural history of cystoid macular edema in pseudophakic bullous keratopathy. J Cataract Refract Surg 1990; 16: 163-9.